Synthetic Biology Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Synthetic Biology Market 

5.1. COVID-19 Landscape: Synthetic Biology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Synthetic Biology Market, By Technology

8.1. Synthetic Biology Market, by Technology, 2024-2033

8.1.1. PCR Technology

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. NGS Technology

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Bioprocessing Technology

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Genome Editing Technology

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Other Technologies

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Synthetic Biology Market, By Product

9.1. Synthetic Biology Market, by Product, 2024-2033

9.1.1. Enzymes

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Oligonucleotide/Oligo Pools and Synthetic DNA

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Xeno-Nucleic Acids

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Cloning Technologies Kits

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Chassis Organism

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Synthetic Biology Market, By Application 

10.1. Synthetic Biology Market, by Application, 2024-2033

10.1.1. Healthcare

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Non-healthcare

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Synthetic Biology Market, By End-Use 

11.1. Synthetic Biology Market, by End-Use, 2024-2033

11.1.1. Academic and Government Research Institutes

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Biotechnology and Pharmaceutical Companies

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Synthetic Biology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Technology (2021-2033)

12.1.2. Market Revenue and Forecast, by Product (2021-2033)

12.1.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Technology (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Technology (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Technology (2021-2033)

12.2.2. Market Revenue and Forecast, by Product (2021-2033)

12.2.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Technology (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Technology (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Technology (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Technology (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Technology (2021-2033)

12.3.2. Market Revenue and Forecast, by Product (2021-2033)

12.3.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Technology (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Technology (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Technology (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Technology (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Technology (2021-2033)

12.4.2. Market Revenue and Forecast, by Product (2021-2033)

12.4.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Technology (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Technology (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Technology (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Technology (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Technology (2021-2033)

12.5.2. Market Revenue and Forecast, by Product (2021-2033)

12.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Technology (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Technology (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

Chapter 13. Company Profiles

13.1. Codexis, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bota Biosciences Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Creative Enzymes.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Creative Biogene.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Illumina, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Enbiotix, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. New England Biolabs

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Merck Kgaa (Sigma-Aldrich Co. Llc)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Novozymes

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Euro fins Scientific

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms